COVID-19 and global equity for health: The good, the bad, and the wicked

PLoS Med. 2021 Oct 1;18(10):e1003797. doi: 10.1371/journal.pmed.1003797. eCollection 2021 Oct.

Elvin H Geng¹, Michael J A Reid^{2

3}, Eric Goosby^{2

3}, Quarraisha Abdool-Karim^{4

5}

¹ Division of Infectious Diseases, Department of Medicine and Center for Dissemination and Implementation in the Institute for Public Health, Washington University in St. Louis, United States of America.
² Institute for Global Health Sciences, University of California, San Francisco, California, United States of America.
³ Department of Medicine, University of California, San Francisco, California, United States of America.
⁴ Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.
⁵ Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, United States of America.

Abstract

Elvin Geng and co-authors discuss monitoring and achieving equity in provision of vaccines for COVID-19.

The authors received no specific funding for this work.